Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Arvinas Inc. (ARVN) PT Lowered to $16 at BTIG
May 2, 2025 5:35 AM EDTBTIG analyst Jeet Mukherjee lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $16.00 (from $69.00) while maintaining a Buy rating.
The analyst comments "ARVN reported 1Q25 earnings, and together with partner Pfizer (PFE, Not Rated), announced a re-prioritization of vepdegestrant's development... More
